Selected research
Industry Growth & Trends
Global Male Infertility Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Male Infertility Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Male Infertility Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Male Infertility Treatment market include Zhejiang Xianju Pharmaceutical Co.,Ltd., Church & Dwight, Livzon Pharmaceutical Group Inc., Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd., Bayer, Bristol Myers Squibb, SCSA diagnostics and Merck Serono, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Male Infertility Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Male Infertility Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Male Infertility Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Male Infertility Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Male Infertility Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Male Infertility Treatment Market by Company
Zhejiang Xianju Pharmaceutical Co.,Ltd.
Church & Dwight
Livzon Pharmaceutical Group Inc.
Eli Lilly and Company
GeneScience Pharmaceuticals Co., Ltd.
Bayer
Bristol Myers Squibb
SCSA diagnostics
Merck Serono
Intas Pharma
Intas Biopharmaceuticals
Halotech DNA
Cadila
Aytu BioScience
ASKA Pharmaceutical Co., Ltd.
Andrology Solutions
Abeona Therapeutics Inc.
Male Infertility Treatment Segment by Type
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Sperm Penetration Assay
DNA Fragmentation Technique
Computer Assisted Semen Analysis
Male Infertility Treatment Segment by Application
Hospitals
Clinics
Others
Male Infertility Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Male Infertility Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Male Infertility Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Male Infertility Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Male Infertility Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay
- DNA Fragmentation Technique
- Computer Assisted Semen Analysis
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Zhejiang Xianju Pharmaceutical Co.,Ltd.
- Church & Dwight
- Livzon Pharmaceutical Group Inc.
- Eli Lilly and Company
- GeneScience Pharmaceuticals Co., Ltd.
- Bayer
- Bristol Myers Squibb
- SCSA diagnostics
- Merck Serono
- Intas Pharma
- Intas Biopharmaceuticals
- Halotech DNA
- Cadila
- Aytu BioScience
- ASKA Pharmaceutical Co., Ltd.
- Andrology Solutions
- Abeona Therapeutics Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Male Infertility Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Male Infertility Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Male Infertility Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Male Infertility Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Male Infertility Treatment Market Size (2021-2032)
- 1.5.1 North America Male Infertility Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Male Infertility Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Male Infertility Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Male Infertility Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Male Infertility Treatment Market Size Growth Rate (2021-2032)
2 Male Infertility Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Oxidative Stress Analysis
- 2.1.2 Microscopic Examination
- 2.1.3 Sperm Agglutination
- 2.1.4 Sperm Penetration Assay
- 2.1.5 DNA Fragmentation Technique
- 2.1.6 Computer Assisted Semen Analysis
- 2.2 Global Male Infertility Treatment Market Size by Type
- 2.2.1 Global Male Infertility Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Male Infertility Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Male Infertility Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Male Infertility Treatment Market Size by Regions
- 2.3.1 North America Male Infertility Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Male Infertility Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Male Infertility Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Male Infertility Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Male Infertility Treatment Market Size Breakdown by Type (2021-2026)
3 Male Infertility Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Clinics
- 3.1.3 Others
- 3.2 Global Male Infertility Treatment Market Size by Application
- 3.2.1 Global Male Infertility Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Male Infertility Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Male Infertility Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Male Infertility Treatment Market Size by Regions
- 3.3.1 North America Male Infertility Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Male Infertility Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Male Infertility Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Male Infertility Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Male Infertility Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Male Infertility Treatment Industry Trends
- 4.2 Male Infertility Treatment Industry Drivers
- 4.3 Male Infertility Treatment Industry Opportunities and Challenges
- 4.4 Male Infertility Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Male Infertility Treatment Revenue (2021-2026)
- 5.2 Global Male Infertility Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Male Infertility Treatment Key Company Headquarters & Area Served
- 5.4 Global Male Infertility Treatment Company, Product Type & Application
- 5.5 Global Male Infertility Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Male Infertility Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Male Infertility Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Male Infertility Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zhejiang Xianju Pharmaceutical Co.,Ltd.
- 6.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Company Information
- 6.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Business Overview
- 6.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product Portfolio
- 6.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
- 6.2 Church & Dwight
- 6.2.1 Church & Dwight Company Information
- 6.2.2 Church & Dwight Business Overview
- 6.2.3 Church & Dwight Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Church & Dwight Male Infertility Treatment Product Portfolio
- 6.2.5 Church & Dwight Recent Developments
- 6.3 Livzon Pharmaceutical Group Inc.
- 6.3.1 Livzon Pharmaceutical Group Inc. Company Information
- 6.3.2 Livzon Pharmaceutical Group Inc. Business Overview
- 6.3.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product Portfolio
- 6.3.5 Livzon Pharmaceutical Group Inc. Recent Developments
- 6.4 Eli Lilly and Company
- 6.4.1 Eli Lilly and Company Company Information
- 6.4.2 Eli Lilly and Company Business Overview
- 6.4.3 Eli Lilly and Company Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eli Lilly and Company Male Infertility Treatment Product Portfolio
- 6.4.5 Eli Lilly and Company Recent Developments
- 6.5 GeneScience Pharmaceuticals Co., Ltd.
- 6.5.1 GeneScience Pharmaceuticals Co., Ltd. Company Information
- 6.5.2 GeneScience Pharmaceuticals Co., Ltd. Business Overview
- 6.5.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product Portfolio
- 6.5.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
- 6.6 Bayer
- 6.6.1 Bayer Company Information
- 6.6.2 Bayer Business Overview
- 6.6.3 Bayer Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bayer Male Infertility Treatment Product Portfolio
- 6.6.5 Bayer Recent Developments
- 6.7 Bristol Myers Squibb
- 6.7.1 Bristol Myers Squibb Company Information
- 6.7.2 Bristol Myers Squibb Business Overview
- 6.7.3 Bristol Myers Squibb Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bristol Myers Squibb Male Infertility Treatment Product Portfolio
- 6.7.5 Bristol Myers Squibb Recent Developments
- 6.8 SCSA diagnostics
- 6.8.1 SCSA diagnostics Company Information
- 6.8.2 SCSA diagnostics Business Overview
- 6.8.3 SCSA diagnostics Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 SCSA diagnostics Male Infertility Treatment Product Portfolio
- 6.8.5 SCSA diagnostics Recent Developments
- 6.9 Merck Serono
- 6.9.1 Merck Serono Company Information
- 6.9.2 Merck Serono Business Overview
- 6.9.3 Merck Serono Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck Serono Male Infertility Treatment Product Portfolio
- 6.9.5 Merck Serono Recent Developments
- 6.10 Intas Pharma
- 6.10.1 Intas Pharma Company Information
- 6.10.2 Intas Pharma Business Overview
- 6.10.3 Intas Pharma Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Intas Pharma Male Infertility Treatment Product Portfolio
- 6.10.5 Intas Pharma Recent Developments
- 6.11 Intas Biopharmaceuticals
- 6.11.1 Intas Biopharmaceuticals Company Information
- 6.11.2 Intas Biopharmaceuticals Business Overview
- 6.11.3 Intas Biopharmaceuticals Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Intas Biopharmaceuticals Male Infertility Treatment Product Portfolio
- 6.11.5 Intas Biopharmaceuticals Recent Developments
- 6.12 Halotech DNA
- 6.12.1 Halotech DNA Company Information
- 6.12.2 Halotech DNA Business Overview
- 6.12.3 Halotech DNA Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Halotech DNA Male Infertility Treatment Product Portfolio
- 6.12.5 Halotech DNA Recent Developments
- 6.13 Cadila
- 6.13.1 Cadila Company Information
- 6.13.2 Cadila Business Overview
- 6.13.3 Cadila Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cadila Male Infertility Treatment Product Portfolio
- 6.13.5 Cadila Recent Developments
- 6.14 Aytu BioScience
- 6.14.1 Aytu BioScience Company Information
- 6.14.2 Aytu BioScience Business Overview
- 6.14.3 Aytu BioScience Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Aytu BioScience Male Infertility Treatment Product Portfolio
- 6.14.5 Aytu BioScience Recent Developments
- 6.15 ASKA Pharmaceutical Co., Ltd.
- 6.15.1 ASKA Pharmaceutical Co., Ltd. Company Information
- 6.15.2 ASKA Pharmaceutical Co., Ltd. Business Overview
- 6.15.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product Portfolio
- 6.15.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
- 6.16 Andrology Solutions
- 6.16.1 Andrology Solutions Company Information
- 6.16.2 Andrology Solutions Business Overview
- 6.16.3 Andrology Solutions Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Andrology Solutions Male Infertility Treatment Product Portfolio
- 6.16.5 Andrology Solutions Recent Developments
- 6.17 Abeona Therapeutics Inc.
- 6.17.1 Abeona Therapeutics Inc. Company Information
- 6.17.2 Abeona Therapeutics Inc. Business Overview
- 6.17.3 Abeona Therapeutics Inc. Male Infertility Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Abeona Therapeutics Inc. Male Infertility Treatment Product Portfolio
- 6.17.5 Abeona Therapeutics Inc. Recent Developments
7 North America
- 7.1 North America Male Infertility Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Male Infertility Treatment Market Size by Country (2021-2026)
- 7.3 North America Male Infertility Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Male Infertility Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Male Infertility Treatment Market Size by Country (2021-2026)
- 8.3 Europe Male Infertility Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Male Infertility Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Male Infertility Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Male Infertility Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Male Infertility Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Male Infertility Treatment Market Size by Country (2021-2026)
- 10.3 South America Male Infertility Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Male Infertility Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Male Infertility Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Male Infertility Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst